Will Bayer Supplement-Drug Combo Draw Other Firms Into New Market?
This article was originally published in The Tan Sheet
Executive Summary
FDA's silence about Bayer's launch of Aspirin with Heart Advantage could speak volumes about a possible new marketing opportunity